02-Sep-15 China's economic downturn plus other factors, including overcapacity and tightening regulations, mean the next two to three years could be challenging for the foreign chemical and pharmaceutical companies located there. [image: Want China Times]

02-Sep-15 Industry leaders have called upon the Government to take strong measures to drive the consumption of medical devices in the country, bring clarity to regulatory policy, correct inverse import duties and provide fiscal incentives to give the domestic manufacture of medical devices a strong impetus for growth, and turn India into a global innovation hub for medical technology. [image: ET Healthworld]

26-Aug-15 China is aiming to control “wildly” growing stem cell therapy, issuing its first regulation covering the largely controversial medical procedure. “Only eligible hospitals can work with stem cells in clinical trials for research and there must not be fees or advertising,” said the National Health and Family Planning Commission. [image: Liu Haifeng / Xinhua Press / Corbis]

19-Aug-15 A new guideline allows foreign drugs to undergo clinical trials in their home country and in China at the same pace, speeding up approval procedures for new drugs that are badly needed in China. Clinical trials of new foreign drugs in China normally lag behind those in the home country. [image: Alamy / Daily Mail]

14-Aug-15 China's medical technology sector growth exceeds the global average, but medical technology imports are declining as foreign investors are hampered by "buy local" guidelines and murky registration criteria. Local producers are under pressure to modernise and the government is funding innovation. [image: PolyOne]